First National Bank of South Miami’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$28.7K Sell
345
-115
-25% -$9.62K 0.02% 196
2023
Q1
$35.1K Hold
460
0.03% 201
2022
Q4
$38K Hold
460
0.03% 203
2022
Q3
$36K Hold
460
0.03% 204
2022
Q2
$34K Hold
460
0.02% 219
2022
Q1
$41K Hold
460
0.02% 228
2021
Q4
$52K Hold
460
0.03% 219
2021
Q3
$58K Hold
460
0.04% 206
2021
Q2
$62K Hold
460
0.04% 195
2021
Q1
$62K Hold
460
0.05% 177
2020
Q4
$65K Hold
460
0.06% 170
2020
Q3
$51K Hold
460
0.05% 169
2020
Q2
$51K Hold
460
0.06% 160
2020
Q1
$36K Hold
460
0.05% 167
2019
Q4
$44K Hold
460
0.04% 172
2019
Q3
$37K Hold
460
0.04% 191
2019
Q2
$39K Hold
460
0.04% 192
2019
Q1
$42K Hold
460
0.04% 191
2018
Q4
$38K Buy
+460
New +$37.1K 0.04% 194

Other funds holding XBI

First National Bank of South Miami's XBI Position: Q2 2023 in Review

First National Bank of South Miami reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 25% in Q2 2023, selling an estimated $9.62K and leaving 345 shares worth $28.7K. The position accounts for 0.02% of the portfolio, ranked #196.

First National Bank of South Miami first reported a position in XBI in Q4 2018 and has held it in 19 quarters since. The position peaked at $65K in Q4 2020. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

  • First National Bank of South Miami held 345 shares of State Street SPDR S&P Biotech ETF worth $28.7K as of Q2 2023.
  • First National Bank of South Miami sold 115 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $9.62K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of First National Bank of South Miami's portfolio in Q2 2023, its #196 holding.
  • First National Bank of South Miami first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 19 quarters since.
  • First National Bank of South Miami's State Street SPDR S&P Biotech ETF position peaked at $65K in Q4 2020.
  • 713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on First National Bank of South Miami's 13F filing for Q2 2023, filed 12 Jul 2023.